- Report
- April 2025
- 169 Pages
Global
From €5337EUR$5,850USD£4,561GBP
- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- April 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- March 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- March 2025
- 175 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- July 2024
- 105 Pages
Global
From €4333EUR$4,750USD£3,704GBP
- Report
- October 2024
- 136 Pages
North America
From €3649EUR$4,000USD£3,119GBP
- Report
- August 2022
- 118 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- August 2022
- 120 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- March 2024
- 200 Pages
Global
From €3786EUR$4,150USD£3,236GBP
- Report
- February 2024
- 182 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- November 2023
- 190 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- April 2025
- 50 Pages
Global
From €2417EUR$2,650USD£2,066GBP
- Report
- April 2025
- 50 Pages
Global
From €2417EUR$2,650USD£2,066GBP
- Report
- March 2025
- 215 Pages
China
From €3649EUR$4,000USD£3,119GBP
- Report
- March 2025
- 109 Pages
China
From €1642EUR$1,800USD£1,403GBP

Enalapril is a drug used to treat cardiovascular diseases, such as hypertension, congestive heart failure, and myocardial infarction. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to constrict. This allows the blood vessels to relax, reducing blood pressure and improving blood flow. Enalapril is available in both oral and injectable forms, and is often prescribed in combination with other medications.
Enalapril is a widely used drug in the cardiovascular market, and is often prescribed as a first-line treatment for hypertension. It is also used to treat other cardiovascular conditions, such as congestive heart failure and myocardial infarction. It is generally well-tolerated, with few side effects.
The enalapril market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Teva Pharmaceuticals. Show Less Read more